Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 120, Issue 9, Pages 3106-3119
Publisher
American Society for Clinical Investigation
Online
2010-08-10
DOI
10.1172/jci43565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system
- (2010) Erich M Ehlert et al. BMC NEUROSCIENCE
- A dicer-independent miRNA biogenesis pathway that requires Ago catalysis
- (2010) Sihem Cheloufi et al. NATURE
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Human tRNA-derived small RNAs in the global regulation of RNA silencing
- (2010) D. Haussecker et al. RNA
- Essential and overlapping functions for mammalian Argonautes in microRNA silencing
- (2009) H. Su et al. GENES & DEVELOPMENT
- Low-level shRNA Cytotoxicity Can Contribute to MYC-induced Hepatocellular Carcinoma in Adult Mice
- (2009) Shelly Beer et al. MOLECULAR THERAPY
- The promises and pitfalls of RNA-interference-based therapeutics
- (2009) Daniela Castanotto et al. NATURE
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- The expression patterns of genes involved in the RNAi pathways are tissue-dependent and differ in the germ and somatic cells of mouse testis
- (2008) E GONZALEZGONZALEZ et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Importance of Translation and Nonnucleolytic Ago Proteins for On-Target RNA Interference
- (2008) Ligang Wu et al. CURRENT BIOLOGY
- Hepatic function is preserved in the absence of mature microRNAs
- (2008) Nicholas J. Hand et al. HEPATOLOGY
- Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi Therapeutic
- (2008) Jeffery C Giering et al. MOLECULAR THERAPY
- Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo
- (2008) Ryan L Boudreau et al. MOLECULAR THERAPY
- Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes
- (2008) Toshiaki Watanabe et al. NATURE
- Capped small RNAs and MOV10 in human hepatitis delta virus replication
- (2008) Dirk Haussecker et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MicroRNA Biogenesis Is Required for Mouse Primordial Germ Cell Development and Spermatogenesis
- (2008) Katsuhiko Hayashi et al. PLoS One
- Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
- (2008) J. L. McBride et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing
- (2008) A. Azuma-Mukai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites
- (2008) R. Sandberg et al. SCIENCE
- Bidirectional Transcription Directs Both Transcriptional Gene Activation and Suppression in Human Cells
- (2008) Kevin V. Morris et al. PLoS Genetics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started